Patent ID: 9745345
Date: 2017-08-29
CPC Classifications: A61K,A61P,C07K

Claim:
1. An anti-tumor polypeptide consisting of an amino acid sequence selected from the group consisting of: FPGSDRF (SEQ ID NO: 15); X-FPGSDRF (SEQ ID NO: 16); FPGSDRF-Z (SEQ ID NO: 17); and X-FPGSDRF-Z (SEQ ID NO: 18); wherein various capital letters denote amino acids as follows: F: phenylalanine; P: proline; G: glycine; D: aspartic acid; R: arginine; S is a phosphorylated serine residue; X and Z are an amino acid residue or an amino acid sequence, respectively; X is one selected from the group consisting of F, (R) Z is one selected from the group consisting of A, (G) n is an integer greater than or equal to 0; and the N-terminus of the polypeptide is acetylated and the C-terminus of the polypeptide is amidated.